Cefuroxime sodium/sulbactam sodium intravenous - Shenzhen Salubris Pharmaceuticals
Latest Information Update: 24 Nov 2015
At a glance
- Originator Shenzhen Salubris Pharmaceuticals
- Class Antibacterials; Cephalosporins; Penicillins
- Mechanism of Action Beta lactamase inhibitors; Cell wall inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Respiratory tract infections; Urinary tract infections
Most Recent Events
- 24 Nov 2015 Clinical trials in Urinary tract infections in China (IV)
- 24 Nov 2015 Clinical trials in Respiratory tract infections in China (IV)